KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biolife Solutions (BLFS) FCF Margin (2016 - 2025)

Biolife Solutions (BLFS) has disclosed FCF Margin for 16 consecutive years, with 3.5% as the latest value for Q4 2025.

  • Quarterly FCF Margin fell 732.0% to 3.5% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 11.06% through Dec 2025, down 10.0% year-over-year, with the annual reading at 11.06% for FY2025, 10.0% down from the prior year.
  • FCF Margin for Q4 2025 was 3.5% at Biolife Solutions, up from 3.47% in the prior quarter.
  • The five-year high for FCF Margin was 33.04% in Q2 2024, with the low at 32.3% in Q3 2023.
  • Average FCF Margin over 5 years is 4.52%, with a median of 3.21% recorded in 2021.
  • The sharpest move saw FCF Margin tumbled -6137bps in 2021, then soared 5570bps in 2024.
  • Over 5 years, FCF Margin stood at 6.27% in 2021, then tumbled by -249bps to 21.91% in 2022, then skyrocketed by 100bps to 0.04% in 2023, then skyrocketed by 25108bps to 10.82% in 2024, then plummeted by -68bps to 3.5% in 2025.
  • According to Business Quant data, FCF Margin over the past three periods came in at 3.5%, 3.47%, and 30.8% for Q4 2025, Q3 2025, and Q2 2025 respectively.